Piermont Capital Management Llc decreased its stake in Spectrum Pharmaceuticals Inc. (SPPI) by 42.31% based on its latest 2017Q4 regulatory filing with the SEC. Piermont Capital Management Llc sold 64,820 shares as the company’s stock declined 9.64% with the market. The institutional investor held 88,372 shares of the health care company at the end of 2017Q4, valued at $1.68 million, down from 153,192 at the end of the previous reported quarter. Piermont Capital Management Llc who had been investing in Spectrum Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $1.68 billion market cap company. The stock decreased 4.79% or $0.83 during the last trading session, reaching $16.5. About 929,378 shares traded. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has risen 143.80% since April 29, 2017 and is uptrending. It has outperformed by 132.25% the S&P500.
Clark Estates Inc decreased its stake in Fluor Corp New (FLR) by 33.33% based on its latest 2017Q4 regulatory filing with the SEC. Clark Estates Inc sold 100,000 shares as the company’s stock rose 9.18% while stock markets declined. The institutional investor held 200,000 shares of the military and government and technical company at the end of 2017Q4, valued at $10.33 million, down from 300,000 at the end of the previous reported quarter. Clark Estates Inc who had been investing in Fluor Corp New for a number of months, seems to be less bullish one the $8.43 billion market cap company. The stock increased 1.28% or $0.76 during the last trading session, reaching $60.22. About 1.29 million shares traded or 0.06% up from the average. Fluor Corporation (NYSE:FLR) has risen 8.50% since April 29, 2017 and is uptrending. It has underperformed by 3.05% the S&P500.
Piermont Capital Management Llc, which manages about $208.82 million and $304.80M US Long portfolio, upped its stake in Rambus Inc. (NASDAQ:RMBS) by 77,860 shares to 115,670 shares, valued at $1.65 million in 2017Q4, according to the filing. It also increased its holding in Weight Watchers International (NYSE:WTW) by 7,140 shares in the quarter, for a total of 33,180 shares, and has risen its stake in Northwestern Corporation.
Among 6 analysts covering Spectrum Pharma (NASDAQ:SPPI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Spectrum Pharma had 12 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Thursday, November 5 by RBC Capital Markets. The stock has “Buy” rating by FBR Capital on Tuesday, April 10. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, August 7 report. The firm has “Buy” rating by Jefferies given on Wednesday, June 7. The firm has “Hold” rating by Zacks given on Thursday, August 27. Jefferies maintained the shares of SPPI in report on Thursday, August 24 with “Buy” rating. The stock has “Buy” rating by Jefferies on Monday, October 9. On Wednesday, August 16 the stock rating was reinitiated by H.C. Wainwright with “Buy”. Jefferies maintained Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) on Friday, February 10 with “Buy” rating.
Since March 21, 2018, it had 0 buys, and 18 selling transactions for $12.13 million activity. Another trade for 4,350 shares valued at $71,123 was made by GUSTAFSON KURT A on Wednesday, March 28. 90,000 shares were sold by SHROTRIYA RAJESH C MD, worth $1.36M. 5,740 shares were sold by Riga Thomas J, worth $107,603. 4,200 shares valued at $78,278 were sold by Krassner Stuart Mitchell on Wednesday, March 21.
Analysts await Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to report earnings on May, 1. They expect $-0.28 earnings per share, down 55.56% or $0.10 from last year’s $-0.18 per share. After $-0.29 actual earnings per share reported by Spectrum Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -3.45% EPS growth.
Investors sentiment decreased to 1.63 in 2017 Q4. Its down 1.21, from 2.84 in 2017Q3. It turned negative, as 26 investors sold SPPI shares while 28 reduced holdings. 27 funds opened positions while 61 raised stakes. 78.22 million shares or 9.25% more from 71.60 million shares in 2017Q3 were reported. Renaissance Techs Limited Liability stated it has 6.18 million shares or 0.13% of all its holdings. Alliancebernstein LP holds 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 133,375 shares. Prudential has invested 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Fny Managed Accounts Limited Co stated it has 763 shares or 0.01% of all its holdings. Thrivent For Lutherans has invested 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Teachers Retirement Systems Of The State Of Kentucky owns 23,300 shares for 0.01% of their portfolio. Mason Street Advsrs Ltd holds 23,563 shares. California Pub Employees Retirement Sys reported 204,113 shares stake. Plante Moran Advisors Lc holds 0.09% or 8,350 shares in its portfolio. Primecap Management Ca holds 0.07% or 4.57M shares in its portfolio. Virginia Retirement Et Al reported 12,400 shares or 0% of all its holdings. Tci Wealth Advsr, Arizona-based fund reported 247 shares. Utd Service Automobile Association stated it has 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Rhumbline Advisers holds 210,642 shares. D E Shaw & holds 0.05% or 1.99 million shares.
Among 19 analysts covering Fluor Corporation (NYSE:FLR), 9 have Buy rating, 0 Sell and 10 Hold. Therefore 47% are positive. Fluor Corporation had 59 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, July 31 by UBS. The rating was upgraded by Deutsche Bank to “Buy” on Thursday, January 12. As per Thursday, February 22, the company rating was maintained by Credit Suisse. The firm earned “Hold” rating on Friday, August 4 by DA Davidson. Cowen & Co maintained Fluor Corporation (NYSE:FLR) rating on Friday, July 31. Cowen & Co has “Outperform” rating and $62 target. The rating was upgraded by S&P Research to “Buy” on Thursday, October 8. The stock has “Buy” rating by Canaccord Genuity on Monday, July 31. The stock of Fluor Corporation (NYSE:FLR) earned “Hold” rating by Barclays Capital on Tuesday, December 12. The firm has “Outperform” rating given on Friday, July 31 by FBR Capital. KeyBanc Capital Markets maintained the stock with “Overweight” rating in Wednesday, February 21 report.
Since February 23, 2018, it had 0 buys, and 10 selling transactions for $7.38 million activity. HERNANDEZ CARLOS M sold $1.76 million worth of stock or 30,257 shares. 3,908 shares were sold by Flowers Garry William, worth $224,320 on Tuesday, March 6. $213,547 worth of Fluor Corporation (NYSE:FLR) was sold by Stanski Bruce A. BARNARD RAY F. sold $1.15 million worth of Fluor Corporation (NYSE:FLR) on Wednesday, February 28. 3,889 shares were sold by Chopra Robin K, worth $224,350 on Friday, March 9. 3,882 Fluor Corporation (NYSE:FLR) shares with value of $222,942 were sold by Bustamante Jose Luis M..
Analysts await Fluor Corporation (NYSE:FLR) to report earnings on May, 3 after the close. They expect $0.76 EPS, up 33.33% or $0.19 from last year’s $0.57 per share. FLR’s profit will be $106.34M for 19.81 P/E if the $0.76 EPS becomes a reality. After $0.70 actual EPS reported by Fluor Corporation for the previous quarter, Wall Street now forecasts 8.57% EPS growth.
Investors sentiment increased to 0.83 in Q4 2017. Its up 0.02, from 0.81 in 2017Q3. It increased, as 48 investors sold FLR shares while 150 reduced holdings. 60 funds opened positions while 104 raised stakes. 118.31 million shares or 2.82% more from 115.07 million shares in 2017Q3 were reported. Lesa Sroufe & holds 2.48% of its portfolio in Fluor Corporation (NYSE:FLR) for 58,145 shares. Jpmorgan Chase Communications accumulated 436,815 shares. Nomura Asset Mngmt Limited invested in 24,057 shares. Texas Permanent School Fund holds 0.02% or 38,185 shares. Sun Life invested in 0% or 305 shares. 108,548 are held by Great West Life Assurance Can. State Street invested in 0.03% or 6.12M shares. Balyasny Asset Mgmt Lc holds 0.01% or 41,209 shares in its portfolio. Caisse De Depot Et Placement Du Quebec holds 0.32% of its portfolio in Fluor Corporation (NYSE:FLR) for 2.68M shares. 51,067 are held by Cornerstone Capital Mgmt Ltd Liability Company. Teacher Retirement Of Texas owns 389,671 shares. Shelton owns 35,110 shares for 0.12% of their portfolio. Panagora Asset Mgmt stated it has 15,504 shares or 0% of all its holdings. Apg Asset Management Nv holds 403,793 shares or 0.03% of its portfolio. Oregon Employees Retirement Fund reported 0.05% in Fluor Corporation (NYSE:FLR).
Clark Estates Inc, which manages about $605.49M US Long portfolio, upped its stake in Smucker J M Co (NYSE:SJM) by 5,000 shares to 45,000 shares, valued at $5.59 million in 2017Q4, according to the filing. It also increased its holding in Time Warner Inc (NYSE:TWX) by 30,000 shares in the quarter, for a total of 57,000 shares, and has risen its stake in Allergan Plc.
The post As Spectrum Pharmaceuticals (SPPI) Market Value Declined, Piermont Capital Management Has Trimmed Its Position; As Fluor New (FLR) Stock Price Rose, Shareholder Clark Estates Has Cut by $5.10 Million Its Stake appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/04/29/as-spectrum-pharmaceuticals-sppi-market-value-declined-piermont-capital-management-has-trimmed-its-position-as-fluor-new-flr-stock-price-rose-shareholder-clark-estates-has-cut-by-5-10-million/
No comments:
Post a Comment